In recent years, our industry has focused on the critical need to improve the therapeutic journey for patients taking complex specialty medications. Too often, however, delays in therapy initiation can extend days, weeks, or longer, depending on the level of administrative and financial hurdles.
As the year winds down and planning for next year ramps up, PharmaVoice editors interviewed industry leaders about mega trends that will impact the life science industry over the next five to 10 years. The recent issue looks at trends ranging from disruptive technology to healthcare consumerism. Two UBC experts added their thought leadership to the mix.
In the pharmaceutical industry, data that offers insight into patient behavior and industry experience are precious commodities. As part of the Express Scripts family of companies, UBC is a vehicle for pharmaceutical and biotech manufacturers to capitalize on a wealth of industry expertise.